Back to search

Article

Novel Insights into the Relationship Between Glucose-Lowering Drugs and Nonalcoholic Fatty Liver Disease and liver function: a Mendelian Randomization Study

2024-08-13

Abstract excerpt

<title>Abstract</title> <p>Objectives The potential risk of nonalcoholic fatty liver disease (NAFLD) and liver toxicity attributed to glucose-lowering medications is uncertain. The objective of this study was to explore the causal relationship between these factors through the implementation of a Mendelian randomization (MR) analysis. Methods Two-sample MR, summary-data-based MR (SMR), and colocalization analys...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dc769fe5-34b8-5f3c-8c46-d452283b587f
DOI
10.21203/rs.3.rs-4759170/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Insights into the Relationship Between Glucose-Lowering Drugs and Nonalcoholic Fatty Liver Disease and liver function: a Mendelian Randomization StudyDOI 10.21203/rs.3.rs-4759170/v1
Select a neighboring publication to make it the new centre.